The California STEM Reporter
SEE OTHER BRANDS

Catch up with science and technology news from California

The California STEM Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The California STEM Reporter.

Press releases published on June 13, 2025

Flow Cytometry Market Hits US$10.3B by 2032: Why Every Lab Needs a FACS Flow Cytometer?

Flow Cytometry Market Hits US$10.3B by 2032: Why Every Lab Needs a FACS Flow Cytometer?

Delray Beach, FL, June 13, 2025 (GLOBE NEWSWIRE) -- Ever wondered how scientists peek inside our cells, analyzing their secrets to diagnose diseases or develop life-saving therapies? It's all thanks to flow cytometry, a dynamic field transforming …

Rose Hill Apothecary Executes First Major International Export Deal, Supplying Research-Grade Psilocybin to Brazil

Rose Hill Apothecary Executes First Major International Export Deal, Supplying Research-Grade Psilocybin to Brazil

RUNAWAY BAY, Jamaica, June 13, 2025 (GLOBE NEWSWIRE) -- Rose Hill Apothecary (“The Company” or “Rose Hill”), a global leader in the research and intellectual property of premium psilocybin products, today announced the successful execution of its first …

Tiziana Life Sciences to Present at the Bio International Convention

Tiziana Life Sciences to Present at the Bio International Convention

NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) (“Tiziana” or the “Company”), a biotechnology company developing breakthrough immunomodulation therapies with its lead development candidate, intranasal foralumab, a …

Introducing Surfshark Everlink: patented self-healing VPN infrastructure for stable VPN protection

Introducing Surfshark Everlink: patented self-healing VPN infrastructure for stable VPN protection

Surfshark, a leading provider of VPN services, unveils Surfshark Everlink, an industry-first patented (patents: US11190491B1, US20240080302A1) technology designed to deliver greater VPN connection stability. Surfshark Everlink is a supporting, self-healing …

Game Pill’s HANGRY™ to Be Showcased with Live Demos at Pixel Power Play during Toronto Games Week

Game Pill’s HANGRY™ to Be Showcased with Live Demos at Pixel Power Play during Toronto Games Week

TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- Game Pill is thrilled to announce that its snack‑‘n‑slash RPG, HANGRY, will be available for live demonstration at Power Pixel Play, a new Toronto gaming event hosted by Toronto Community Meetup Powered By Twitch …

Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025

Medera and Novoheart Presented Breakthroughs in Human mini-Heart Platforms and Gene Therapy at ISSCR 2025

Showcased 7 presentations at ISSCR 2025, including a featured oral presentation on first-in-human gene therapy for heart failure, powered by their proprietary human mini-Heart technology. FDA-backed human-based screening platform recognized as an animal- …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025

Panavance Therapeutics Announces Promising Misetionamide (GP-2250) Phase 1 Clinical Trial Interim Findings in Pancreatic Cancer at BIO 2025

Interim analysis shows misetionamide is very well tolerated in combination with gemcitabine; rates of confirmed response, stable disease, and progression-free survival compare favorably with gemcitabine monotherapy BERWYN, PA, June 13, 2025 (GLOBE NEWSWIRE …

Grace Therapeutics to Participate in the 2025 BIO International Conference

Grace Therapeutics to Participate in the 2025 BIO International Conference

PRINCETON, N.J., June 13, 2025 (GLOBE NEWSWIRE) -- Grace Therapeutics, Inc. (Nasdaq: GRCE) (Grace Therapeutics or the Company), a late-stage, biopharma company advancing GTx-104, a clinical-stage, novel, injectable formulation of nimodipine being developed …

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

HANOVER, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that members of its executive leadership team will …

June 2025 Letter to Shareholders of Nvni Group Limited

June 2025 Letter to Shareholders of Nvni Group Limited

~ Building on a Strong Foundation through Operational Progress and Strategic Initiatives ~ NEW YORK, June 13, 2025 (GLOBE NEWSWIRE) -- Nuvini Group Limited (Nasdaq: NVNI) (“Nuvini” or the “Company”), a leading acquirer of private B2B SaaS companies in …

Official Announcement: Legal Statement on Trademark and App Name by RBH

Official Announcement: Legal Statement on Trademark and App Name by RBH

San Diego, USA, June 13, 2025 (GLOBE NEWSWIRE) -- Today, RBH Infinity Exchange has issued a legal statement regarding its trademark and app name. The full text is as follows: This exchange and all its operations, services, products, and visual identifiers …

ALL4 Mining Launches User-Friendly Free Cloud Mining Platform to Support Cryptocurrency Enthusiasts Worldwide

ALL4 Mining Launches User-Friendly Free Cloud Mining Platform to Support Cryptocurrency Enthusiasts Worldwide

Buffalo, NY, June 13, 2025 (GLOBE NEWSWIRE) -- ALL4 Mining, a cloud mining platform founded in 2019, has announced the global expansion of its mining services, aiming to make cryptocurrency investment more accessible to both new and existing investors. …

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split

BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will …

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions

GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation and …

reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout

reAlpha Expands Homebuying Platform into Texas, Marking First Step in National Realty Rollout

DUBLIN, Ohio, June 13, 2025 (GLOBE NEWSWIRE) -- reAlpha Tech Corp. (Nasdaq: AIRE) (“reAlpha” or the “Company”), an AI-powered real estate technology company, today announced the expansion of its platform into Texas1 with the launch of real estate brokerage …

New Wave Announces Investment in Cartwheel Robotics, an Advanced Robotics Company Seeking to Build Humanoids for Humans

New Wave Announces Investment in Cartwheel Robotics, an Advanced Robotics Company Seeking to Build Humanoids for Humans

Vancouver, BC, June 13, 2025 (GLOBE NEWSWIRE) -- New Wave Holdings Corp. (“New Wave” or the “Company”) (CSE:NWAI, FWB:0XM0, OTCPK:TRMNF) is pleased to announce that it has made a strategic investment of US$150,000 into Cartwheel Robotics Inc. (“Cartwheel …

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares

LONDON, June 13, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has notified the …

Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress

Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress

– ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (also known as AITL) and transformed follicular lymphoma – – In combination with small molecule inhibitors, ARV-393 …

ORLADEYO® (berotralstat) Approved in Colombia

ORLADEYO® (berotralstat) Approved in Colombia

RESEARCH TRIANGLE PARK, N.C., June 13, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service